MENU

AstraZeneca plc In New Partnership With Controversial Valeant Pharmaceuticals Intl Inc

Canada’s Valeant Pharmaceuticals divides opinion in the investment world. To some it’s the whip-smart upstart feasting on the bloated and bumbling big pharma sector, while to others it’s a rapacious predator, or even a roll-up vehicle that will eventually crash to Earth. But what’s staid and sensible AstraZeneca (LSE: AZN) doing making deals with it?

To find out the strategies to adopt if you want to become one of the growing number of surprise UK millionaires, read this FREE Motley Fool report: '7 Simple Steps For Seeking Serious Wealth' while it remains available!

 

Owain Bennallack owns shares in AstraZeneca. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.